A panel of investors, local business leaders and a former commissioner of the Food and Drug Administration outlined the state of the biotech industry in 2026 — and where Houston could play a role.
A panel of investors, local business leaders and a former commissioner of the Food and Drug Administration outlined the state of the biotech industry in 2026 — and where Houston could play a role.
